Protia Inc. (KOSDAQ:303360)
3,960.00
-10.00 (-0.25%)
At close: Aug 14, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Diagnostic Kits and Diagnostic Equipment Product | 10.04B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostic Kits and Diagnostic Equipment Product Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Analysis Service | 238.80M | Log In | Log In | Log In | Log In | Upgrade |
Analysis Service Growth | 22.84% | Log In | Log In | Log In | Log In | Upgrade |
Other | 240.25M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 21.06% | Log In | Log In | Log In | Log In | Upgrade |
Allergy Diagnosis Reagent | - | Log In | Log In | Log In | Log In | Upgrade |
Allergy Diagnosis Reagent Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Allergy Diagnosis Equipment | - | Log In | Log In | Log In | Log In | Upgrade |
Allergy Diagnosis Equipment Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Point-of-care (POCT) Product Line | - | Log In | Log In | Log In | Log In | Upgrade |
Point-of-care (POCT) Product Line Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostic Reagents (Protia Allergy-Q, etc.) | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostic Equipment (Q-STATION ELITE, etc.) | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 240.25M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 21.06% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Other | 10.46M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -4.18% | Log In | Log In | Log In | Log In | Upgrade |
South Korea | 5.29B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | 15.69% | Log In | Log In | Log In | Log In | Upgrade |
Asia | 3.26B | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | 43.42% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 1.62B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 41.49% | Log In | Log In | Log In | Log In | Upgrade |
North and Central America | 161.30M | Log In | Log In | Log In | Log In | Upgrade |
North and Central America Growth | 50.99% | Log In | Log In | Log In | Log In | Upgrade |
Africa | 110.85M | Log In | Log In | Log In | Log In | Upgrade |
Africa Growth | 38.83% | Log In | Log In | Log In | Log In | Upgrade |
South America | 54.29M | Log In | Log In | Log In | Log In | Upgrade |
South America Growth | 59.47% | Log In | Log In | Log In | Log In | Upgrade |
Other | 10.46M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -4.18% | Log In | Log In | Log In | Log In | Upgrade |